It is noteworthy that our results indicate that EMs patients have low expression levels of HNRNPA2B1 and HNRNPC, even though most other tumors are associated with high expression levels of HNRNPA2B1 and HNRNPC [20], except for in cases with kidney renal clear cell carcinoma [42]. This evidence concerns the gene HNRNPA2B1 and eosinophilia-myalgia syndrome.